Joint Improvements. Any new intellectual property generated by KI PHARMA shall be jointly owned by BIONUMERIK and GRELAN on an equal basis. Each of BIONUMERIK and GRELAN hereby agrees to license its interest in such intellectual property in the manner provided in Sections 11.1 and 11.2.
Appears in 4 contracts
Samples: Joint Venture Agreement (BioNumerik Pharmaceuticals, Inc.), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc)
